Cancer Patient Assistance Programs — Neulasta®
Neulasta FIRST STEP™ Program (Co-pay Card)
The Neulasta FIRST STEP™ Program provides financial assistance to all eligible low-income patients with commercial insurance who need help meeting their Neulasta® co-insurance or co-payment requirement. Please click here for additional details.
SAFETY NET® (Replacement Product)
The Amgen SAFETY NET® Foundation is an established patient-assistance program that provides Amgen product replacement to healthcare providers for eligible patients.
This program provides access to Neulasta® financial assistance for cancer patients through a simple registration and enrollment process. Once enrolled, sponsoring healthcare providers or pharmacists can receive replacement product for SAFETY NET® Foundation patients for 1 year.
Who is eligible for SAFETY NET®?
Uninsured and underinsured patients with limited financial resources are eligible for the SAFETY NET® Foundation. These patients must meet insurance and income eligibility criteria. This program extends medication assistance for all Amgen drugs and is a great resource for providing financial assistance for cancer patients.
How can patients apply for SAFETY NET®?
Patients can apply for patient assistance through a healthcare professional (sponsor). If a sponsor is uncertain about the patient's coverage:
- Start by calling Amgen's Reimbursement Connection® at 1-800-272-9376 for assistance with insurance verification.
If a sponsor has already established that a patient does not have coverage (including Medicare or Medicaid):
- Call the SAFETY NET® Foundation directly at 1-888-762-6436
(888-SN-AMGEN)
How long will the eligibility investigation and enrollment process take?
Eligibility can often be determined over the phone. The enrollment and confirmation process will take approximately 48 hours after receipt of completed enrollment forms by the SAFETY NET® Foundation.
Other under-insured patient assistance
We can help you cut through the confusion - call Reimbursement Connection® directly at 1-800-272-9376. Every attempt will be made to ensure a reimbursement expert is available for your call. If all experts are answering other calls, please leave a message. We will use our best efforts to return your call within 1 business day.
Please click here for more information on Reimbursement Connection®.
Referral to an Independently Run, Third Party Co-payment Assistance Programs for under-insured patients
Access to medication(s) for patients suffering from serious illness is important. Sometimes, the co-payment obligation can pose a financial hardship to you and your family. Several independent, third-party, not-for-profit foundations exist to help you obtain access to treatment with medically appropriate medication(s).
For more information on Partnership for Prescription Assistance please call 1-888-4PPA-NOW (477-2669)
Next: Information on Neutropenia and Cancer >>
Important safety information
Ruptured spleen (including fatal cases), a serious lung problem called acute respiratory distress syndrome, and serious allergic reactions have been reported. Call your doctor or seek emergency care right away if you have abdominal or shoulder tip pain, shortness of breath, trouble breathing, a fast rate of breathing, or any allergic reaction. The most common side effect of this injection is mild to moderate bone pain.
If you have any questions about this information, be sure to discuss them with your doctor. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
© 2010 Amgen. All rights reserved.